WC
TVRD

Woodstock Corp’s Tvardi Therapeutics TVRD Stock Holding History

Woodstock Corp’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,287
Closed -$227K – 174
2023
Q1 		$227K Hold
1,287
– – 0.03% 155
2022
Q4 		$498K Hold
1,287
– – 0.07% 118
2022
Q3 		$434K Buy
1,287
+300
+30% +$109K 0.06% 120
2022
Q2 		$324K Hold
987
– – 0.05% 134
2022
Q1 		$432K Buy
987
+150
+18% +$61.6K 0.05% 134
2021
Q4 		$367K Hold
837
– – 0.04% 154
2021
Q3 		$466K Hold
837
– – 0.05% 138
2021
Q2 		$430K Hold
837
– – 0.05% 145
2021
Q1 		$655K Buy
837
+322
+63% +$220K 0.08% 123
2020
Q4 		$280K Buy
+515
New +$270K 0.04% 160

Other funds holding TVRD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Woodstock Corp's TVRD Position: Q2 2023 in Review

Woodstock Corp sold out of Tvardi Therapeutics (TVRD) in Q2 2023, closing a stake of 1,287 shares — an estimated $227K sold.

Woodstock Corp first reported a position in TVRD in Q4 2020 and held it in 10 quarters. The position peaked at $655K in Q1 2021. 137 funds tracked by Wall St. Rank hold TVRD as of Q2 2023.

  • Woodstock Corp reported no remaining Tvardi Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Woodstock Corp sold 1,287 Tvardi Therapeutics shares in Q2 2023, an estimated $227K.
  • Woodstock Corp first reported a position in Tvardi Therapeutics in Q4 2020 and held it in 10 quarters.
  • Woodstock Corp's Tvardi Therapeutics position peaked at $655K in Q1 2021.
  • 137 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q2 2023.

Based on Woodstock Corp's 13F filing for Q2 2023, filed 7 Jul 2023.